Submitted by Anonymous (not verified) on 16 April 2026 - 14:44
Human medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Date of authorisation: 31/05/2022, Revision: 5, Status: Authorised
Source: